Clinical trial
Validation of Promising Biomarker Assays to Assess Their Diagnostic Performance Characteristics in Africa and Latin America
NCT03047642 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of Promising Biomarker Assays to Assess Their Diagnostic Performance Characteristics in Africa and Latin America
- Lead sponsor
- Foundation for Innovative New Diagnostics, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 27, 2017
- Completion date
- November 27, 2019
- Enrollment
- 2,000 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
acute febrile illnesses